Max Healthcare Institute Ltd. Q2 FY2025 results: revenue ₹1,707 crore, up 25.3% on the year
Max Healthcare Institute Ltd. (MAXHEALTH) reported consolidated revenue from operations of ₹1,707 crore for Q2 FY2025, the quarter ended 30 September 2024, up 25.3% on the same quarter a year earlier. Profit after tax was ₹282 crore, up 1.9% on the year, and earnings per share ₹2.90. The figures are the company's own, from the unaudited results it filed with NSE on 5 November 2024.
The quarter, against the one before and a year earlier
| Line | Q2 FY2025 | Q1 FY2025 | Q2 FY2024 | Change on the year |
|---|---|---|---|---|
| Revenue from operations | 1,707 | 1,543 | 1,363 | +25.3% |
| Other income | 41 | 35 | 45 | -10.2% |
| Total income | 1,748 | 1,578 | 1,409 | +24.1% |
| Cost of materials consumed | 0 | 0 | 0 | n/a |
| Purchases of stock-in-trade | 359 | 330 | 278 | +29.1% |
| Changes in inventories | -10 | -3 | 1 | n/a |
| Employee benefit expense | 284 | 270 | 236 | +20.3% |
| Finance costs | 34 | 24 | 9 | +293.2% |
| Depreciation, depletion and amortisation | 84 | 77 | 58 | +45.4% |
| Other expenses | 624 | 559 | 460 | +35.6% |
| Total expenses | 1,375 | 1,256 | 1,042 | +31.9% |
| Profit before exceptional items and tax | 374 | 321 | 366 | +2.0% |
| Exceptional items | 0 | 0 | 0 | n/a |
| Profit before tax | 374 | 321 | 366 | +2.0% |
| Current tax | 92 | 81 | 71 | +28.7% |
| Deferred tax | 0 | 4 | 19 | -98.8% |
| Total tax | 92 | 85 | 90 | +2.4% |
| Profit after tax | 282 | 236 | 277 | +1.9% |
| Attributable to owners of the parent | 282 | 236 | 0 | n/a |
| Other comprehensive income | -2 | -2 | -4 | n/a |
| Total comprehensive income | 280 | 235 | 272 | +2.6% |
| EPS, basic | ₹2.90 | ₹2.43 | ₹2.85 | +1.8% |
| EPS, diluted | ₹2.88 | ₹2.42 | ₹2.84 | +1.4% |
₹ crore except per share.
Quarterly results, the last 12 quarters
| Q2 FY2024 | Q3 FY2024 | Q4 FY2024 | Q1 FY2025 | Q2 FY2025 | Q3 FY2025 | Q4 FY2025 | Q1 FY2026 | Q2 FY2026 | Q3 FY2026 | Q4 FY2026 | Q1 FY2027 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,363 | 1,335 | 1,423 | 1,543 | 1,707 | 1,868 | 1,910 | 2,028 | 2,135 | 2,068 | 2,143 | 2,366 |
| Expenses | 1,042 | 1,021 | 1,132 | 1,256 | 1,375 | 1,519 | 1,554 | 1,664 | 1,722 | 1,700 | 1,726 | 1,970 |
| Operating profit | 387 | 386 | 382 | 387 | 451 | 499 | 512 | 523 | 575 | 538 | 606 | 598 |
| OPM % | 28% | 29% | 27% | 25% | 26% | 27% | 27% | 26% | 27% | 26% | 28% | 25% |
| Other income | 45 | 46 | 45 | 35 | 41 | 33 | 47 | 37 | 33 | 45 | 48 | 41 |
| Interest | 9 | 11 | 21 | 24 | 34 | 52 | 55 | 55 | 54 | 60 | 67 | 71 |
| Depreciation | 58 | 61 | 70 | 77 | 84 | 98 | 101 | 104 | 108 | 111 | 123 | 132 |
| Exceptional items | 0 | 0 | 0 | 0 | 0 | -74 | 0 | 0 | 0 | -48 | 0 | 0 |
| Profit before tax | 366 | 360 | 336 | 321 | 374 | 309 | 402 | 400 | 446 | 365 | 465 | 436 |
| Tax % | 24% | 20% | 25% | 26% | 25% | 23% | 21% | 23% | -10% | 17% | 26% | 26% |
| Net profit | 277 | 289 | 252 | 236 | 282 | 239 | 319 | 308 | 491 | 301 | 342 | 323 |
| EPS in ₹ | ₹2.85 | ₹2.98 | ₹2.59 | ₹2.43 | ₹2.90 | ₹2.46 | ₹3.28 | ₹3.17 | ₹5.05 | ₹3.10 | ₹3.52 | ₹3.32 |
| Filing | NSE | NSE | NSE | NSE | NSE | NSE | Filing | Filing | Filing | Filing | Filing | Filing |
₹ crore except per share, consolidated, as filed with the exchange. Operating profit is sales less the expenses other than interest and depreciation, OPM is that over sales, and tax % is tax over profit before tax: arithmetic on the filed lines; everything else is as filed. Quarters before December 2024 are from the exchange's earlier results feed, which carries the filed lines without the filing itself; the column links to the exchange's page for the company.
Source
Unaudited consolidated results for the quarter ended 30 September 2024, filed with NSE on 5 November 2024: the result statement. All of Max Healthcare Institute Ltd.'s results: NSE company page.
The same record on your computer
GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.